Cross-Border Impact Ventures
VC Fund
Toronto, Canada
Cross-Border Impact Ventures is a VC fund in Toronto focused on Health Care and Biotechnology. Cross-Border Impact Ventures invests in health technology companies that address the needs of women, children, and adolescents. It has partnered with Grand Challenges Canada to develop a platform that breaks the paradigm of who benefits from leading technologies. The firm was founded in 2019 and is based in Toronto, Canada.
- Total investments:
- 11
- Last investment:
- Lead investor:
- 64%
Last updated:
For AI agents: llms.txt
Industries Cross-Border Impact Ventures invests in
Stages Cross-Border Impact Ventures invests in
Countries Cross-Border Impact Ventures invests in
Round sizes
Round size
- Seed
- $11M–$11M
- Series A
- $7.5M–$14M
- Series B
- $16M–$35M
Investment Focus
Industry
- Health Care 7 (64%)
- Biotechnology 5 (45%)
- Medical 3 (27%)
- Medical Device 2 (18%)
- Artificial Intelligence 2 (18%)
Stage
- Series A 5 (45%)
- Series B 2 (18%)
- Seed 1 (9%)
- Funding Round 1 (9%)
- Venture - Series Unknown 1 (9%)
Country
- United States 4 (36%)
- United Kingdom 3 (27%)
- France 1 (9%)
- Denmark 1 (9%)
Investments
| Company | Description | Round | Links |
|---|---|---|---|
TidalSense
|
CRiL was formed in April 2013 specifically to develop innovative medical devices to diagnose and manage respiratory conditions. They have been building a platform technology, N-Tidal, based on the measurement and analysis of tidal breathing CO2 throughout the entire breath. | $19M / Venture - Series Unknown / Jul 24, 2026 | |
Bactolife
|
Bactolife helps in developing innovative solutions meeting the global need for reducing antimicrobial resistance. Its products are based on minimizing the risk of disease through reduction of virulence, making pathogens unable to establish an active infection. | $35.2M / Series B / Jan 06, 2026 | |
Pendulum Systems
|
Pendulum Systems is an AI company that builds software with agnostic solutions for geolocation. It runs on a device and requires no new hardware, connectivity, or access to GPS. It is built to protect the warfighter. It specializes in machine learning, artificial intelligence, geolocation, and embedded software. | $11M / Seed / Feb 06, 2025 | |
OncoLens
|
OncoLens develops technologies that improve cancer treatment planning, simplify tumor board management, facilitate survivorship care planning, and automate accreditation and quality reporting through an intelligent workflow engine that streamlines business processes and enables more informed clinical decision-making. | $16M / Series B / Oct 24, 2024 | |
Axena Health
|
Axena Health is a women-led company dedicated to improving the lives of women with pelvic floor disorders by leveraging the power of digital technology. | $9.4M / Series A / Jun 04, 2024 | |
Raydiant Oximetry
|
Raydiant Oximetry is a medical device company focused on improving outcomes for mothers and babies during childbirth. The company develops a low-cost, non-invasive biomedical device to monitor the oxygen levels in fetal blood. It develops and distributes a non-invasive technology that directly monitors a babies' oxygenation during pregnancy.This technology will lead to better patient care and greatly reduce the number of unnecessary cesarean sections.Founded in 2015 by Neil Ray, Raydiant Oximetry is headquartered in Mountain View, California. | $7.5M / Series A / Jun 04, 2024 | |
Sonio
|
Sonio is an artificial intelligence for fetal ultrasound, helping practitioners analyse and diagnose congenital malformations. | $14.3M / Series A / Jul 11, 2023 | |
Daye
|
Daye has set out to build a new brand for female health products “designed with women in mind.” The startup’s first product is a newly developed tampon that uses CBD to help tackle period cramps (or dysmenorrhea) as an alternative to traditional painkillers (CBD is the extract derived from the flower of the industrial hemp plant, a legal relativeto marijuana). | $11.6M / Series A / Oct 26, 2022 | |
|
Pendulum Systems
|
Pendulum Systems is an AI company that builds software with agnostic solutions for geolocation. It runs on a device and requires no new hardware, connectivity, or access to GPS. It is built to protect the warfighter. It specializes in machine learning, artificial intelligence, geolocation, and embedded software. | $11M / Seed / May 26, 2022 | |
OxCan
|
OxCan is a startup that uses machine learning and liquid biopsy for early lung cancer detection. | $11M / Series A | |
| See all 11 investments → | |||
Co-Investors
Collaborative Fund
2 deals together
Decisive Point
2 deals together
Lowercarbon Capital
2 deals together
We Venture Capital
2 deals together
Airstream Ventures
1 deal together
Access 48,091 investors
822 industries, 177 countries. Updated daily. Emails and phones included.
Browse database — It's Free!
Find investors for your startup
Search 48,091 investors by industry and country. Emails and phones included.
Similar Investors
Similar industry
Similar stage
Similar country
Featured in Investor Lists
Recommended lists
FAQ
What does Cross-Border Impact Ventures invest in?
Cross-Border Impact Ventures invests primarily in Health Care, Biotechnology and Medical startups, most often at Series A and Series B stage. Most of the 11 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.
What is Cross-Border Impact Ventures's check size?
Cross-Border Impact Ventures typically joins rounds of $11M–$11M at Seed, $7.5M–$14M at Series A and $16M–$35M at Series B. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Cross-Border Impact Ventures participates in.
When did Cross-Border Impact Ventures last invest?
The most recent investment recorded for Cross-Border Impact Ventures closed in Jul 2026. Shizune tracks 11 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.
Is Shizune's investor data accurate?
Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.
Contact your first 100 investors today
Find who invests in your industry, stage, and country. Download investor list with emails in 5 minutes.
Find investors — It's Free!
Continue with Google
Continue with LinkedIn
